Artificial Intelligence

RIVANNA Secures $30.5M from BARDA to Advance Accuro XV Musculoskeletal Imaging

Accuro XV integrates ultrasound-based bone and 3D soft-tissue imaging technology with AI-enabled software....

ConcertAI's TeraRecon Partners with ClariPi for AI-Enabled Medical Imaging on Eureka Platform

- Advanced visualization and AI leader TeraRecon, a ConcertAI company, announced a strategic partnership with ClariPi, an innovative medical imaging AI company, to integrate ClariPi's solutions into its Eureka platform. With this partnership, TeraRecon continues to expand its offerings to enhance clinical workflows, delivering comprehensive medical imaging AI solutions to customers worldwide....

Korean startup Lunit accelerates expansion across Middle East with new supply contract

Supplying AI-powered breast screening solution to Dr. Sulaiman Al Habib Medical Group for the next three years...

Japan produces world's first report on brain activation by Plasmacluster Technology

Validation of the mechanism of its enhancing effect on human work performance by measuring brain function ...

Medlinker's MedGPT Performs 96% As Well As Top Human Doctors

In a Livestreamed Real-World Assessment, MedGPT's AI Doctors Rival Diagnostic Accuracy of China's Leading Doctors...

Lark Health and Desert Oasis Healthcare Announce Expanded Partnership

Lark Health, the leading AI-powered digital care coaching company for the prevention and management of chronic conditions, and Desert Oasis Healthcare (DOHC), a member of Heritage Provider Network, today announced their expanded partnership where DOHC will offer Lark's Prevention program and CDC-recognized Diabetes Prevention program to their patients....

Verantos' AI Advancement in Neurology Bolstered by Groundbreaking Migraine Real-World Evidence

Technology enables inference of subjective outcomes from routinely collected data...

Optina's REPHRASE Study Validates Innovative Alzheimer's Test

Optina Diagnostics' pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of Alzheimer's Disease (AD). This landmark study is focused on validating the novel awAIr™-Cerebral Amyloid Status (CAS) test, an innovative tool intended to provide physicians with definitive information about Alzheimer's pathology, enabling improved management of cognitive impairments....

DiamiR Biosciences Partners with JADBio to Utilize Machine Learning in Assay Development

DiamiR Biosciences, a developer of innovative non-invasive blood-based diagnostic tests for brain health and other diseases, today announced that it has entered into an agreement with JADBio to utilize its Automated Machine Learning (AutoML) Platform and Services for development of predictive models based on DiamiR's microRNA panels and other factors for risk assessment in Alzheimer's disease and Rett syndrome....